Pricing and reimbursement
The Icelandic Medicines Agency (IMA) makes decisions on medicine prices guided by the objective of the Medicinal Products Act that the use of medicinal products in Iceland should be based on a rational and cost-effective foundation, and also decides on reimbursement as appropriate under the Medicinal Products Act and regulations issued on the basis of it.


Applications and forms
Application for maximum wholesale price, reimbursement and publication of medicinal products.

Management of GTIN numbers
See more
Verðaðgangur
Verðaðgangur veitir heimild til að uppfæra umboðsmannaverð og breyta viðmiðunargjaldmiðli, sem tryggir að verðskrá og gjaldmiðlar séu í samræmi við núverandi markaðsskilyrði.
